Survival analysis and causes of mortality in patients with lupus nephritis

Long-term mortality and renal outcome in a cohort of 100 patients with Lupus Nephritis

(2010) Mikkel Faurschou et al.   ARTHRITIS CARE & RESEARCH

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

(2009) F A Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence of cancer among female patients with systemic lupus erythematosus in Korea

(2009) Kwi Young Kang et al.   CLINICAL RHEUMATOLOGY

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality

(2009) RO Escárcega et al.   LUPUS

Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort

(2009) M. I. Danila et al.   RHEUMATOLOGY

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

(2009) David Isenberg et al.   RHEUMATOLOGY

Chronic Kidney Disease as a Predictor of Cardiovascular Disease (from the Framingham Heart Study)

(2008) Nisha I. Parikh et al.   AMERICAN JOURNAL OF CARDIOLOGY

Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus

(2008) Murray B. Urowitz et al.   JOURNAL OF RHEUMATOLOGY

The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study

(2007) S Bernatsky et al.   ANNALS OF THE RHEUMATIC DISEASES